Alicia Elbert

1.2k total citations
32 papers, 223 citations indexed

About

Alicia Elbert is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Alicia Elbert has authored 32 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 5 papers in Nephrology. Recurrent topics in Alicia Elbert's work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Diabetes Treatment and Management (8 papers) and Diabetes Management and Research (6 papers). Alicia Elbert is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Diabetes Treatment and Management (8 papers) and Diabetes Management and Research (6 papers). Alicia Elbert collaborates with scholars based in Argentina, Germany and Colombia. Alicia Elbert's co-authors include Liliana N. Contreras, Estela Cardoso, Alejandro L. Arregger, Laura Schreier, Regina Wikinski, Omar R. Tumilasci, Gabriela Berg, Graciela López, Daniel R. Aquilano and A Zucchini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Arteriosclerosis Thrombosis and Vascular Biology and Atherosclerosis.

In The Last Decade

Alicia Elbert

26 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicia Elbert Argentina 7 100 54 42 36 36 32 223
Mieko Saito Japan 11 111 1.1× 94 1.7× 54 1.3× 28 0.8× 50 1.4× 20 352
Abdullah Olgun Türkiye 10 61 0.6× 24 0.4× 19 0.5× 12 0.3× 63 1.8× 28 355
Y Makita Japan 6 41 0.4× 16 0.3× 68 1.6× 34 0.9× 23 0.6× 6 178
D J Philbrick Canada 13 39 0.4× 41 0.8× 42 1.0× 24 0.7× 59 1.6× 16 380
Jinni Hong China 11 54 0.5× 18 0.3× 64 1.5× 44 1.2× 44 1.2× 19 354
Claire Maynard United Kingdom 7 52 0.5× 14 0.3× 70 1.7× 13 0.4× 70 1.9× 10 349
Yukie Nagai Japan 10 82 0.8× 32 0.6× 27 0.6× 4 0.1× 52 1.4× 26 387
H. Bethge Germany 12 92 0.9× 89 1.6× 17 0.4× 28 0.8× 60 1.7× 46 350
Ákos Baráth Hungary 10 42 0.4× 15 0.3× 11 0.3× 72 2.0× 38 1.1× 21 276
Justine Beck United States 8 128 1.3× 12 0.2× 34 0.8× 186 5.2× 135 3.8× 10 390

Countries citing papers authored by Alicia Elbert

Since Specialization
Citations

This map shows the geographic impact of Alicia Elbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Elbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Elbert more than expected).

Fields of papers citing papers by Alicia Elbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Elbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Elbert. The network helps show where Alicia Elbert may publish in the future.

Co-authorship network of co-authors of Alicia Elbert

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Elbert. A scholar is included among the top collaborators of Alicia Elbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Elbert. Alicia Elbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Corral, Pablo, et al.. (2025). Impact of SGLT2 Inhibitors on Lipoproteins in Type 2 Diabetes. Current Diabetes Reports. 25(1). 16–16. 3 indexed citations
3.
Bril, Fernando & Alicia Elbert. (2024). Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern?. Metabolism. 162. 156066–156066. 6 indexed citations
4.
5.
Elbert, Alicia, et al.. (2021). Relación entre enfermedad cardiovascular y renal en una muestra de pacientes con diabetes del mundo real. SHILAP Revista de lepidopterología. 92(2). 165–173. 2 indexed citations
6.
Elbert, Alicia, et al.. (2018). Hemoglobina glicada (HbAa1c). Utilidad y limitaciones en pacientes con enfermedad renal crónica. Redalyc (Universidad Autónoma del Estado de México). 38(1). 65–83. 2 indexed citations
7.
Elbert, Alicia, et al.. (2017). Tratamiento de las hiperuricemias. Dialnet (Universidad de la Rioja). 37(2). 104–114.
8.
Imperiali, Nora, et al.. (2016). Hiperuricemia, enfermedad renal crónica y trasplante renal (parte II). Dialnet (Universidad de la Rioja). 36(1). 48–53. 1 indexed citations
9.
Morales, Enrique, et al.. (2016). Alteraciones glucémicas en los pacientes con enfermedad renal crónica. Nefrología. 36(2). 133–140.
10.
Elbert, Alicia, Tetsuo Machida, Masami Murakami, et al.. (2014). Do Insulin Resistance Conditions Further Impair the Lipid and Inflammatory Profile in End-Stage Renal Disease Patients on Hemodialysis?. Metabolic Syndrome and Related Disorders. 12(4). 220–226. 3 indexed citations
11.
Miksztowicz, Verónica, Mary McCoy, Laura Schreier, et al.. (2012). Endothelial Lipase Activity Predicts High-Density Lipoprotein Catabolism in Hemodialysis. Arteriosclerosis Thrombosis and Vascular Biology. 32(12). 3033–3040. 11 indexed citations
12.
Rosso, Leonardo Gómez, Tomás Meroño, Alicia Elbert, et al.. (2011). HDL-associated enzymes and proteins in hemodialysis patients. Clinical Biochemistry. 45(3). 243–248. 11 indexed citations
13.
Brites, Fernando, Alicia Elbert, Leonardo Gómez Rosso, et al.. (2010). [Relation between paraoxonase activity, other HDL components and inflammatory state in hemodialyzed patients].. PubMed. 70(6). 508–12. 4 indexed citations
14.
Brites, Fernando, et al.. (2006). Chronic renal failure in diabetic patients increases lipid risk factors for atherosclerosis. Diabetes Research and Clinical Practice. 75(1). 35–41. 5 indexed citations
15.
16.
Schreier, Laura, et al.. (2004). Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients. Metabolism. 53(8). 1013–1015. 5 indexed citations
17.
Schreier, Laura, et al.. (2003). Lipoprotein alterations in hemodialysis: Differences between diabetic and nondiabetic patients. Metabolism. 52(1). 116–121. 18 indexed citations
18.
19.
Elbert, Alicia & H. Z. Levinson. (1979). Steuerung der Diapause bei Larven von Trogoderma variabile über die Individuendichte. Die Naturwissenschaften. 66(12). 621–622. 2 indexed citations
20.
Elbert, Alicia. (1978). Die Pfeilhaare der Megatominae (Col. Dermestidae): Ein Abwehrsystem. Journal of Pest Science. 51(7). 109–110. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mieko Saito Breakdown of academic impact, for papers by Abdullah Olgun Breakdown of academic impact, for papers by Y Makita Breakdown of academic impact, for papers by D J Philbrick Breakdown of academic impact, for papers by Jinni Hong Breakdown of academic impact, for papers by Claire Maynard Breakdown of academic impact, for papers by Yukie Nagai Breakdown of academic impact, for papers by H. Bethge Breakdown of academic impact, for papers by Ákos Baráth Breakdown of academic impact, for papers by Justine Beck
Rankless by CCL
2026